NewsBenzinga泽纳斯生物制药将在第六届IgG4相关疾病国际研讨会和2026年ACR汇聚大会上发布INDIGO三期试验评估Obexelimab在IgG4-RD中的新数据 泽纳斯生物制药将在第六届IgG4相关疾病国际研讨会和2026年ACR汇聚大会上发布INDIGO三期试验评估Obexelimab在IgG4-RD中的新数据 Benzinga 2026.09.22 11:15 (GMT+0) Open on Benzinga Other news T1 Energy Stock Plunges: What's Going On? Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT Nike CEO Says Co Aims To Double The Units Of Product Created In Under 14 Months By FY31